For the month of November, the U.S. Food and Drug Administration (FDA) reports that 4 out of the 61 (6.6%) total seafood entry line refusals were of shrimp for reasons related to banned antibiotics.
So far this year, there has been a total of 47 shrimp entry lines refused for reasons related to banned antibiotics. Absent a significant change in trends in December, the FDA is likely to report the smallest number of shrimp entry lines refused for banned antibiotics since 2006.
The four shrimp entry line refusals in November were from three exporters in three different countries:
  • Dulceria Los Alamos S.A. de C.V. (Mexico), a company that was added to Import Alert 16-129 (“Detention Without Physical Examination of Seafood Products Due to Nitrofurans”) on October 23, 2018 for its shipments of dried shrimp, had one entry line refused for shrimp contaminated with veterinary drug residues (as well as misbranding) by the Division of Southwest Imports on November 6, 2018;
  • Minh Phu – Hau Giang Seafood Joint Stock Company (Vietnam), a company that is not currently listed on Import Alert 16-124 (“Detention Without Physical Examination of Aquaculture Seafood Products Due to Unapproved Drugs”), Import Alert 16-127 (“Detention Without Physical Examination of Crustaceans Due to Chloramphenicol”), or Import Alert 16-129, had one entry line refused for breaded shrimp contaminated with nitrofurans and veterinary drug residues by the Division of West Coast Imports on November 6, 2018 and one entry line refused for shrimp contaminated with veterinary drug residues by the Division of West Coast Imports on November 13, 2018; and
  • Chaohu Jiayi Foodstuffs Co., Ltd. (China), a company that is not currently exempted from Import Alert 16-131 (“Detention Without Physical Examination of Aquacultured Shrimp, Dace, and Eel from China – Presence of New Animal Drugs and/or Unsafe Food Additives”), had one entry line refused for breaded shrimp contaminated with veterinary drug residues by the Division of West Coast Imports on November 20, 2018.
The FDA also refused one entry line of shrimp from Corlim Marine Exports (India) in November due to the presence of salmonella.